Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. paracetamol
Show results for
Products
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Paracetamol Articles & Analysis

4 news found

Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

– Company to Webcast Investor Event on September 30th at 8:00 p.m. ET – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 13, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present additional data from the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment ...

ByAlnylam Pharmaceuticals, Inc.


Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Alfa Chemistry Now Offers Pharmaceutical and Drug Standards for Drug Discovery

Pharmaceutical Impurities Certified Reference Materials The pharmaceutical impurities certified reference materials that are frequently used include: acetaminophen impurities, aspirin (acetylsalicyclic acid) impurities, diphenhydramine hydrochloride impurities, lidocaine impurities, paracetamol (acetaminophen) impurities, naproxen impurities and others. ...

ByAlfa Chemistry


WHO/Europe Warn Extreme Heat on Health Impact

WHO/Europe Warn Extreme Heat on Health Impact

Do not give acetylsalicylic acid (aspirin) or paracetamol. Position an unconscious person on his or her side. Seek further information on the health effects of heat and how to prevent them. ...

ByScarlet Tech Ltd.


FDA consumer health information - new steps aimed at cutting risks from acetaminophen

FDA consumer health information - new steps aimed at cutting risks from acetaminophen

FDA has taken new steps to cut the risk of severe liver injury associated with use of the pain- and fever- reducing drug acetaminophen. These steps include asking makers of prescription products that contain acetaminophen to limit how much of it is placed in each tablet or capsule. Learn more about FDA's measures, and the safe use products containing acetaminophen, at ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT